Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Aniluxx Biotechnology Logo
Aniluxx Biotechnology Growth Score
34
CB Rank
144720
Heat Score
41
Aniluxx Biotechnology is a development stage biopharmaceutical company
Founded
obfuscation
PrivateNon-equity Assistance Raleigh, North Carolina, United States11-50 www.aniluxx.com
Biotechnology
Health Care
Medical
Overview

Aniluxx Biotechnology
Total Funding
obfuscation
Growth Score
34
Heat Score
41

Total Funding
obfuscation
Non-equity Assistance raised
obfuscation
Growth Score34
1 pts
in past quarter
Heat Score 41
5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Aniluxx Biotechnology

CB Rank
144720
Aniluxx Biotechnology is a development stage biopharmaceutical company
Founded
obfuscation
PrivateNon-equity Assistance Raleigh, North Carolina, United States11-50 www.aniluxx.com
Biotechnology
Health Care
Medical

Funding Rounds

Non-equity Assistance
OBF
in
obfuscation
Debt Financing
OBF
in
obfuscation
Debt Financing
OBF
in
obfuscation

Key People

Details

Operating Status Active
Company Type For Profit
Founders  Stefan Weiss
About the Company

Aniluxx Biotechnology is a development stage biopharmaceutical company with a mission to improve companion animal health and well-being. The Company’s strategy is to translate its deep pipeline of topically formulated therapeutics, predicated on compounds that have already been identified as safe and effective in humans, into therapies for dogs,

cats, and horses, that are easy to apply, virtually unnoticeable, and absent the harsh side effects of systemic medicines.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ALX 101
An investigational topical therapy for treating canine allergic dermatitis, designed to alleviate symptoms of atopic dermatitis in dogs.
PET Delivery Technology™
A proprietary topical delivery system that deposits active ingredients and excipients simultaneously on the skin surface for improved treatment application.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Non Equity Assistance - Aniluxx Biotechnology Logo
Non Equity Assistance - Aniluxx Biotechnology
1
obfuscation
MassChallengeNon-equity Assistance
obfuscation
Non Equity Assistance - Aniluxx Biotechnology Logo
Non Equity Assistance - Aniluxx Biotechnology
1
obfuscation
MassChallengeNon-equity Assistance
obfuscation
Non Equity Assistance - Aniluxx Biotechnology Logo
Non Equity Assistance - Aniluxx Biotechnology
1
obfuscation
MassChallengeNon-equity Assistance
obfuscation
Non Equity Assistance - Aniluxx Biotechnology Logo
Non Equity Assistance - Aniluxx Biotechnology
1
obfuscation
MassChallengeNon-equity Assistance
obfuscation
Non Equity Assistance - Aniluxx Biotechnology Logo
Non Equity Assistance - Aniluxx Biotechnology
1
obfuscation
MassChallengeNon-equity Assistance

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Non Equity Assistance - Aniluxx Biotechnology Logo
Non Equity Assistance - Aniluxx Biotechnology
1
obfuscation
MassChallengeNon-equity Assistance
obfuscation
Non Equity Assistance - Aniluxx Biotechnology Logo
Non Equity Assistance - Aniluxx Biotechnology
1
obfuscation
MassChallengeNon-equity Assistance
obfuscation
Non Equity Assistance - Aniluxx Biotechnology Logo
Non Equity Assistance - Aniluxx Biotechnology
1
obfuscation
MassChallengeNon-equity Assistance
obfuscation
Non Equity Assistance - Aniluxx Biotechnology Logo
Non Equity Assistance - Aniluxx Biotechnology
1
obfuscation
MassChallengeNon-equity Assistance
obfuscation
Non Equity Assistance - Aniluxx Biotechnology Logo
Non Equity Assistance - Aniluxx Biotechnology
1
obfuscation
MassChallengeNon-equity Assistance

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1

Employee Profiles

News

News and Press

News•Jan 29, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$393.4KThis year, Aniluxx Biotechnology is projected to spend $393.4K on IT, according to Aberdeen.

Active Website Tech Count

3Aniluxx Biotechnology is actively using 3 technologies for its website, according to BuiltWith. These include Euro and  CommonCrawl Top 200m.
Sub-Organizations
Frequently Asked Questions

Where is Aniluxx Biotechnology's headquarters? Aniluxx Biotechnology is located in Raleigh, North Carolina, United States.Who invested in Aniluxx Biotechnology? Aniluxx Biotechnology has 2 investors including MassChallenge and  North Carolina Biotechnology Center.When was the last funding round for Aniluxx Biotechnology? Aniluxx Biotechnology closed its last funding round on
obfuscation
from a Non-equity Assistance round.Who are Aniluxx Biotechnology's competitors? Alternatives and possible competitors to Aniluxx Biotechnology may include Zoetis, Elanco, and  Boehringer Ingelheim.How much funding has Aniluxx Biotechnology raised to date? Aniluxx Biotechnology has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|